Wei Dong Jiang
Oprichter bij SHANGHAI HENLIUS BIOTECH, INC.
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Wei Dong Jiang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2009 | - |
| Oprichter | 01-12-2009 | - |
Loopbaan van Wei Dong Jiang
Eerdere bekende functies van Wei Dong Jiang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Henlius Biopharmaceuticals, Inc.
 Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 | - |
| Oprichter | 01-01-2009 | - |
Opleiding van Wei Dong Jiang
| Zhejiang University | Undergraduate Degree |
| University of Giessen | Doctorate Degree |
Statistieken
Internationaal
| China | 3 |
| Verenigde Staten | 2 |
| Duitsland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SHANGHAI HENLIUS BIOTECH, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Henlius Biopharmaceuticals, Inc.
Henlius Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Henlius Biopharmaceuticals, Inc. focuses on development and commercialization of mAb-based therapeutics biosimilars and biobetter for malignant tumors and auto-immune diseases. The company was founded by Scott Liu and Paul Liu in 2009 and is headquartered in Fremont, CA. | Health Technology |
- Beurs
- Insiders
- Wei Dong Jiang
- Ervaring
